AME

Business profile & competitive position

AMETEK, Inc. (AME) is classified in the Industrials sector, specifically the Electrical Equipment & Parts industry. Operationally, it is a global manufacturer of electronic instruments and electromechanical devices, organized into two reporting groups. Electronic Instruments (EIG) designs and produces advanced analytical, test and measurement instruments for the process, aerospace, power and industrial markets. Electromechanical (EMG) supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and other industrial markets.

The company’s reported margin and returns help explain why the market gives it a quality-multiple profile. Net margin is 20.0% and return on equity is 14.5%. Those figures are high for a capital-goods manufacturer that serves a broad set of industrial OEMs; they imply meaningful value-added engineering, recurring aftermarket content, and long-dated customer relationships rather than undifferentiated commodity production. A beta of 0.96 also suggests the stock historically tracks the broader market closely, not a highly cyclical industrial proxy.

Financial posture

AMETEK’s current market capitalization is $56.9 billion, with a price-to-earnings ratio of 36.1. Against that valuation, the business posts a 20.0% net margin and a 14.5% ROE. The P/E is materially above what is typical for many diversified industrial names, which tells you the market is pricing in above-average earnings visibility, margin resilience, and continued capital-deployment discipline.

The 10-K numbers reinforce that narrative. In fiscal 2025 AMETEK recorded sales of $7,401.1 million, up 6.6% from 2024, and diluted earnings per share of $6.40, up 7.9%. It also achieved record operating income, net income, orders and backlog. Growth was not purely organic: the company spent $933.2 million in cash, net of cash acquired, to buy Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). From 2021 through Dec. 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales, so mergers and acquisitions are a structural part of the growth model, not an occasional extra.

Strategic priorities & outlook

AMETEK’s most recent 10-K outlines four operational pillars. First, it is executing what it calls the AMETEK Growth Model, targeting high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation, and a superior return on total capital. Second, it pushes Operational Excellence through lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization, and artificial intelligence. Third, it pursues strategic acquisitions with compelling strategic, technical and cultural fit in adjacent or complementary markets aligned with secular growth themes. Fourth, it is expanding globally and in emerging markets, maintaining best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico, and Serbia for customer proximity and international growth.

Those priorities are visible in the 2025 results: sales growth of 6.6%, EPS growth of 7.9%, record orders and backlog, and nearly $1 billion deployed on two technology-focused deals. Geography matters as well—52% of EIG’s net sales and 42% of EMG’s net sales were to customers outside the United States, with approximately 22,500 employees worldwide as of Dec. 31, 2025.

Macro & geopolitical exposure

Because AMETEK is classified as Electrical Equipment & Parts within Industrials, its exposures map broadly to manufacturing activity, industrial capital spending, and multi-industry end markets rather than a single consumer-driven demand curve. It is naturally exposed to aerospace and defense cycles, medical capital-equipment demand, automation adoption, and power/industrial process activity. This mix creates both cyclical and secular demand levers.

Structural headwinds and tailwinds for the industry include global trade policy, tariffs on components and finished goods, currency translation, and supply-chain inputs such as semiconductors, copper, specialty metals, and rare-earth materials. With over half of EIG sales and 42% of EMG sales going to non-U.S. customers, exchange-rate moves can meaningfully affect translated revenue and margins. Regulatory standards in aerospace, defense, and medical also shape product certification cycles and compliance costs. Energy-price volatility and the pace of industrial automation investment can further influence order patterns across AMETEK’s customer base.

Recent developments

Recent headlines have centered on ownership activity and the upcoming earnings event rather than operational surprises. On Oct. 15, 2026, Zacks published “Is AMETEK (AME) Outperforming Other Computer and Technology Stocks This Year?” That classification is worth noting: while AMETEK’s GICS sector is Industrials, some data providers place it alongside technology-oriented industrials because of its instrumentation and measurement content. The same day, AMETEK announced that its third-quarter 2026 earnings call and webcasted investor conference call would take place Nov. 3, 2026, before the market opens. Also on Oct. 15, defenseworld.net noted that Krilogy Financial LLC had purchased AMETEK shares, and on Oct. 9, 2026, Gamma Investing LLC was reported to have added to its position. These are disclosure events, not directional forecasts, but they show institutional interest heading into the next report.

Earnings behavior & post-earnings drift

AMETEK’s earnings track record over the last eight reported quarters is flawless: 8 beats out of 8, a 100% beat rate, with an average earnings surprise of 4%. The post-earnings price drift, however, has been modest. Across those eight quarters, the average 5-day move after the report was 0.46%, classified as “flat.” In other words, the stock has usually already reflected the beat by the time the numbers are public, and the following week shows minimal directional follow-through.

The most recent four quarters illustrate the pattern. On Aug. 4, 2026, AMETEK reported EPS of $2.09 against an estimate of $1.99, a 5% surprise; the stock rose 0.28% the next day and 0.89% over the next five days. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and was down 0.33% after five days. On Feb. 3, 2026, EPS of $2.01 beat the $1.94 estimate by 3.6%; the stock dipped 0.48% the next day before rising 1.83% over five days. On Oct. 30, 2025, EPS of $1.89 beat the $1.76 estimate by 7.4%; the stock gained 1.91% the next day but gave it back, falling 0.54% over the next five sessions.

The takeaway is consistency on the results side and randomness on the price side: AMETEK reliably exceeds the published consensus, but the market’s real expectation may already be embedded, so post-report drift has averaged near zero. The next scheduled report is Nov. 3, 2026, before the open, with a current consensus EPS estimate of $2.11. The current share price is $248.17, with a 50-day EMA of $244.51 and an RSI of 52.8.

For a deeper dive into how institutional analysts are interpreting AMETEK’s valuation, acquisition strategy, and upcoming earnings setup, review the full institutional verdict and consensus detail rather than relying on headline numbers alone.